BM-06021

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBM-06021
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsThrombosisMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A